Table 2.
Category | P-value | Molecules |
---|---|---|
Lipid Metabolism | 9.42E-05-2.56E-02 | ABCA12, ABCA2, ABHD5, ACSBG2, ACSL1, ADF,ADIPOR2, ALDH1A1, AOX1,CD38, CEBPB,CETP, CTSS, DCI,DRD3,GOT2, GRB10,HMGCL, HTT,INSIG1, LASS4, LPAR1,LPIN1,MTMR6, MTMR7,PCTP, PDK4,PHYH, PIK3CD,PLA2G7, PNPLA2, PRKAG2, PSAP,RAB5A,SGPL1, SLC27A1,UCP3 |
Molecular Transport | 9.42E-05-1.93E-02 | ABCA12, ABCA2, ABHD5, ACSL1, ADFP, ADIPOR2,ALDH1A1, ARNTL,CD38, CEBPB,CETP, CTSS, DCI,DRD3, F3, GHR,GOT2,HCK, HTT,INSIG1, LASS4, LPAR1,LPIN1, NEB, P2RY2,PCTP, PIK3CD, PLN, PNPLA2, PSAP,SGK1, SLC27A1,TGFB2, TGFB3,TRPC3, UCN3, UCP3, UGP2,VWF |
Small Molecule Biochemistry | 9.42E-05-2.6E-02 | ABCA12,ABCA2, ABHD5, ACSBG2, ACSL1,ADAM10,ADFP,ADIPOR2,ALDH1A1, ALDH6A1, AOX1,CD38, CEBPB,CETP, CTSS, DCI, DRD3,FOXO3, GHR,GLS,GOT2, GRB10,HMGCL,HTT,INSIG1, LASS4, LPAR1,MTMR6,MTMR7, NUDT3,PCTP, PDK4, PIK3CD,PLA2G7, PNPLA2,LPIN1, PHYH, PRKAG2,PRPS1, PRPS2, PSAP,RAB5A, RPIA,SGPL1, SLC27A1, TGFB2,TGFB3, UCN3, UCP3,UGDH,UGP2 |
Carbohydrate Metabolism | 3.36E-04-2.6E-02 | ABHD5, ADAM10, ADIPOR2,ALDH2, CEBPB,CETP, FOXO3, GHR, HTT,IMPA2,MTMR6, MTMR7,PCTP, PDK4, PIK3CD,PLA2G7, PRKAG2, PSAP,RAB5A, RPIA,SOCS3, TGFB2, TGFB3,UCN3, UCP3,UGDH, UGP2 |
Cell Death | 3.36E-04 - 2.64E-02 | ALDH1A1, ATPA1, BAG3, CD99, CDK2AP1, CEBPB, CTSS, DAPK1, DCN, FGF1, FGFR2, FOXO3, GHR, HTT, IL15, MCL1, NEFH, PAX5, PKN2, RGS4, SGK1, SGPL1, SIAH1, SPARC, SRF, TGFB2, TGFB3, TPM3 |
The biological interpretation of expressional data was performed using Ingenuity Pathway Analysis 7.0 (IPA, Ingenuity Systems Inc., Redwood City, CA). The genes included in the analysis were shown to be differential between F and L and/or between G+ and G- by either microarray or real-time RT-PCR. Genes are presented in alphabetical order for each category. The genes over expressed in muscles with high (F or G+) and low glycogen content (L and G-) are in bold and normal characters, respectively. Genes in italic were differentially regulated between models (F vs. L or G+ vs. G-).